- Exchange: EN Amsterdam
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Fornix Biosciences NV
+ Add to WatchlistFORBI:NA
0.3000 EUR 0.00000.00%As of 03:00:00 ET on 05/21/2013.
Snapshot for Fornix Biosciences NV (FORBI)
| Open: | 0.3000 | Day's Range: | 0.3000 - 0.3000 | Volume: | 200 |
|---|---|---|---|---|---|
| Previous Close: | 0.3000 | 52wk Range: | 0.2800 - 1.0000 | 1-Yr Rtn: | +7.26% |
Key Statistics for FORBI
| Current P/E Ratio (ttm) | 30.0000 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. AEX | 1.2407 |
| Earnings Per Share (ttm) | 0.0100 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 2.41 |
| Shares Outstanding (M) | 8.05 |
| 30 Day Average Volume | 7,123 |
| Price/Book (mrq) | 1.7765 |
| Price/Sale (ttm) | 9.4985 |
| Dividend Indicated Gross Yield | 156.67% |
| Cash Dividend (EUR) | 0.4700 |
| Last Dividend | 09/20/2012 |
| 5 Year Dividend Growth | -25.22% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FORBI
Company Profile & Key Executives for FORBI
Fornix Biosciences NV is a biomedical company that produces and sells medical appliances, diagnostic and therapeutic allergen products and microbiological products as well as patented drugs of third parties. The company further develops and sells theranostics for the diagnosis and treatment of diseases caused by bacteria and moulds, and diagnostic medical equipment.
| M E T Pigeaud WijdeveldCEO/Member-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FORBI News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page